Advertisement

Anticancer and biochemical effects of Viscum album L. protein extracts on HeLa cells

  • Sophie MavrikouEmail author
  • Vasileios Tsekouras
  • Maria-Argyro Karageorgou
  • Georgia Moschopoulou
  • Spyridon KintziosEmail author
Original Article
  • 31 Downloads

Abstract

European mistletoe (Viscum album) is a medicinal plant with significant anticancer properties. In vitro callus production provides an essential alternative for biomass production and medicinal compounds propagation. In this study, we investigated (a) the biotechnological production of somaclonal proteins from mistletoe callus propagation and (b) the in vitro cytotoxic properties of these mistletoe protein extracts against cervical cancer. Mistletoe proteins (MPEs) were extracted from natural resources (plant leaves and stems) and in vitro propagated variant calluses. Potential cytotoxic effects of the extracted proteins on HeLa cells were assessed by the MTT proliferation assay, whereas oxidative damage and induction of apoptosis were measured fluorometrically by the reactive oxygen species (ROS) sensitive carboxy-H2-DCFDA method and caspase-3 activation assays, respectively. Electrophoretic results indicated differences in the protein bands between callus and donor plant tissues. Leaf and stem protein extracts (PEs) demonstrated a strong impact on HeLa cells viability by promoting oxidative damage and inducing apoptosis in contrast to callus PEs. This study shows that MPEs application in HeLa cells causes oxidative alterations and apoptosis through caspase-3 activation and increased intracellular ROS levels. These findings may be useful for uncovering novel bioactive products of pharmaceutical interest as well as for gaining an understanding of the biochemical pathways of mistletoe proteins in cancer treatment.

Key message

In spite of the low cytotoxicity observed for biotechnologically propagated somaclonal variant calluses, towards cervical cancer, the ability to establish biotechnological production of said mistletoe extracts is important because it allows for standardization of protein production.

Keywords

Anticancer therapeutic strategies Apoptosis Biotechnologically produced proteins HeLa cell line Mistletoe extracts Somaclonal variation 

Abbreviations

Ac-DEVD-CHO

Acetyl-Asp-Glu-Val-Asp-al

Ac-DEVD-pNA

Acetyl-Asp-Glu-Val-Asp p-nitroanilide

BAP

Benzyladenine

CHAPS

3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate

DCF

2,7-Dichlorofluorescein

DMEM

Dulbecco’s modified Eagle’s medium

DOX

Doxorubicin hydrochloride

DMSO

Dimethyl sulfoxide

FBS

Fetal bovine serum

HEPES

2-[4-(2-Hydroxyethyl)piperazin-1-yl]ethanesulfonic acid

kDa

Kilodaltons

ML-I,-II,-III

Mistletoe lectins I,-II,-III

MPEs

Mistletoe protein extracts

MTT

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

NAA

a-Naphthaleneacetic acid

NAC

N-acetyl l-cysteine

PBS

Phosphate-buffered saline

ROS

Reactive oxygen species

SDS

Sodium dodecyl sulfate

SOD

Superoxide dismutase

Notes

Acknowledgements

We warmly acknowledge the support of Dr. Penelopi Bouzioti (Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research “Demokritos) for her critical review of our experiments and associated results.

Author contributions

Methodology, SM, VT, M-AK, GM; investigation, SM, VT, M-AK, GM; data curation, SM, VT; writing—original draft preparation, SM, VT, SK, GM; writing—review and editing, SK; supervision, SK; project administration, GM.

Funding

This work is supported by the Operational Program “Human Resources Development, Education and Lifelong Learning”, Priority Axes 6, 8, 9 co-financed by European Social Fund entitled “Support of Researchers with Emphasis on Senior Researchers” (NSRF 2014-2020).

Compliance with ethical standards

Conflicts of interest

The authors declare no conflict of interest.

References

  1. Twardziok M, Kleinsimon S, Rolff J, Jäger S, Eggert A, Seifert G, Delebinski CI (2016) Multiple active compounds from Viscum album L synergistically converge to promote apoptosis in ewing sarcoma. PLoS ONE 11(9):e0159749.  https://doi.org/10.1371/journal.pone.0159749 CrossRefPubMedPubMedCentralGoogle Scholar
  2. Anonymous (2019) PDQ® Integrative, alternative, and complementary therapies editorial board. PDQ mistletoe extracts. National Cancer Institute, BethesdaGoogle Scholar
  3. Barberaki M, Dermitzaki E, Margioris N, Theodosaki A, Grafakos M, Kintzios S (2015) Protein extracts from somaclonal mistletoe (Viscum album L.) callus with increased tumor cytotoxic activity in vitro. Curr Bioact Compd 11:1.  https://doi.org/10.2174/1573407211666150602215615 CrossRefGoogle Scholar
  4. Baumgartner S, Fluckiger H, Kunz M, Scherr C, Urech K (2014) Evaluation of preclinical assays to investigate an anthroposophic pharmaceutical process applied to mistletoe (Viscum album L.) extracts. Evid-Based Compl Altern.  https://doi.org/10.1155/2014/620974 CrossRefGoogle Scholar
  5. Becker H (1986) Botany of European Mistletoe (Viscum album L.). Oncol Rep 43(1):2–7.  https://doi.org/10.1159/000226413 CrossRefGoogle Scholar
  6. Becker H, Schwarz LZ (1971) In vitro culture of Viscum album L. Z. Pflanzenphysiol 59:273–278Google Scholar
  7. Beuth J, Stoffel B, Ko HL, Buss G, Tunggal L, Pulverer G (1995) Immunostimulating activity of different dosages of mistletoe lectin-1 in patients with mammary carcinoma. Arzneim Forsch 45(4):505–507.  https://doi.org/10.1016/s0944-7113(96)80054-7 CrossRefGoogle Scholar
  8. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72(1):248–254.  https://doi.org/10.1016/0003-2697(76)90527-3 CrossRefPubMedPubMedCentralGoogle Scholar
  9. Brentnall M, Rodriguez-Menocal L, de Guevara R, Cepero E, Boise LH (2013) Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol 14(1):32.  https://doi.org/10.1186/1471-2121-14-32 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Büssing A (1996) Induction of apoptosis by the mistletoe lectins: a review on the mechanisms of cytotoxicity mediated by Viscum album L. Apoptosis 1(1):25–32.  https://doi.org/10.1007/bf00142075 CrossRefGoogle Scholar
  11. Cardoza V, Stewart CN (2004) Brassica biotechnology: progress in cellular and molecular biology. Vitro Cell Dev Biol Plant 40(6):542–551CrossRefGoogle Scholar
  12. Chevallet M, Luche S, Rabilloud T (2006) Silver staining of proteins in polyacrylamide gels. Nat Protoc 1(4):1852–1858.  https://doi.org/10.1038/nprot.2006.288 CrossRefPubMedPubMedCentralGoogle Scholar
  13. de Oliveira Melo MN, Oliveira AP, Wiecikowski AF, Carvalho RS, de Lima Castro J, de Oliveira FAG, Pereira HMG, da Veiga VF, Capella MMA, Rocha L, Holandino C (2018) Phenolic compounds from Viscum album tinctures enhanced antitumor activity in melanoma murine cancer cells. Saudi Pharm J 26(3):311–322.  https://doi.org/10.1016/j.jsps.2018.01.011 CrossRefGoogle Scholar
  14. Efferth T (2019) Biotechnology applications of plant callus cultures. Engineering 5(1):50–59.  https://doi.org/10.1016/j.eng.2018.11.006 CrossRefGoogle Scholar
  15. Eggenschwiler J, Patrignani A, Wagner U, Rehrauer H, Schlapbach R, Rist L, Ramos MH, Viviani A (2006) Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro. Arzneim Forsch 56(06):483–496.  https://doi.org/10.1055/s-0031-1296816 CrossRefGoogle Scholar
  16. Esmaeili F, Shooshtari L, Ghorbanpour M, Etminan A (2014) Assessment of somaclonal variation in Plantago major using molecular markers. JBES 5(4):402–408Google Scholar
  17. Fakheri B, Rahimi M, Tavassoli A, Raissi A (2011) Application of biotechnology in production of medicinal plants. Am Eurasian J Agric Environ Sci 11:439–444Google Scholar
  18. Fukui M, Azuma J, Okamura K (1990) Induction of callus from mistletoe (Viscum album) and interaction with its host cells. Bull Kyoto Prefect Univ For 62:261–269Google Scholar
  19. Gandhi SG, Mahajan V, Bedi YS (2015) Changing trends in biotechnology of secondary metabolism in medicinal and aromatic plants. Planta 241(2):303–317.  https://doi.org/10.1007/s00425-014-2232-x CrossRefPubMedGoogle Scholar
  20. Halasi M, Wang M, Chavan TS, Gaponenko V, Hay N, Gartel AL (2013) ROS inhibitor N-acetyl-l-cysteine antagonizes the activity of proteasome inhibitors. Biochem J 454(2):201–208.  https://doi.org/10.1042/BJ20130282 CrossRefPubMedPubMedCentralGoogle Scholar
  21. Halliwell B (2011) Free radicals and antioxidants-quo vadis? Trends Pharmacol Sci 32:125–130CrossRefGoogle Scholar
  22. Hu J-B, Li Q, Li J (2011) ISSR analysis of somaclonal variation in callus-derived plants of Amorphophallus Rivieri Durieu. Acta Biol Crac Ser Bot 53(1):120–124.  https://doi.org/10.2478/v10182-011-0017-0 CrossRefGoogle Scholar
  23. Hwang WY, Kang MH, Lee SK, Yeom JS, Jung MH (2019) Prolonged stabilization of platinum-refractory ovarian cancer in a single patient undergoing long-term Mistletoe extract treatment: case report. Medicine (Baltimore).  https://doi.org/10.1097/md.0000000000014536 CrossRefPubMedCentralGoogle Scholar
  24. Ikeuchi M, Sugimoto K, Iwase A (2013) Plant callus: mechanisms of induction and repression. Plant Cell 25(9):3159–3173.  https://doi.org/10.1105/tpc.113.116053 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Kintzios S, Barberaki M, Tourgielis P, Aivalakis G, Volioti A (2002) Preliminary evaluation of somaclonal variation for the in vitro production of new toxic proteins from Viscum album L. J Herbs Spices Med Plants 9(23):217–221.  https://doi.org/10.1300/j044v09n02_31 CrossRefGoogle Scholar
  26. Knöpfl-Sidler F, Viviani A, Rist L, Hensel A (2005) Human cancer cells exhibit in vitro individual receptiveness towards different Mistletoe extracts. Pharmazie 60(6):448–454PubMedGoogle Scholar
  27. Kour B, Kour G, Kaul S, Dhar MK (2014) In vitro mass multiplication and assessment of genetic stability of in vitro raised Artemisia absinthium L. plants using ISSR and SSAP molecular markers. Adv Bot.  https://doi.org/10.1155/2014/727020 CrossRefGoogle Scholar
  28. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680–685.  https://doi.org/10.1038/227680a0 CrossRefPubMedPubMedCentralGoogle Scholar
  29. Larkin PJ, Scowcroft WR (1981) Somaclonal variation: a novel source of variability from cell cultures for plant improvement. Theor Appl Genet 60(4):197–214.  https://doi.org/10.1007/bf02342540 CrossRefPubMedGoogle Scholar
  30. Lavastre V, Pelletier M, Saller R, Hostanska K, Girard D (2002) Mechanisms involved in spontaneous and Viscum album agglutinin-I-induced human neutrophil apoptosis: Viscum album agglutinin-I accelerates the loss of antiapoptotic Mcl-1 expression and the degradation of cytoskeletal paxillin and vimentin proteins via caspases. J Immunol 168:1419–1427.  https://doi.org/10.4049/jimmunol.168.3.1419 CrossRefPubMedGoogle Scholar
  31. Lee KP, Lee DW (2013) The identification of in vitro production of lectin from callus cultures of Korean Mistletoe (Viscum album L. var. coloratum). Biosci Biotechnol Biochem 77(4):884–887.  https://doi.org/10.1271/bbb.120962 CrossRefPubMedGoogle Scholar
  32. Longhi A, Mariani E, Kuehn JJ (2009) A randomized study with adjuvant mistletoe versus oral Etoposide on post relapse disease-free survival in osteosarcoma patients. Eur J Integr Med 1(1):27–33.  https://doi.org/10.1016/j.eujim.2009.02.005 CrossRefGoogle Scholar
  33. Lyu SY, Choi SH, Park WB (2002) Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53. Arch Pharm Res 25(1):93.  https://doi.org/10.1007/bf02975269 CrossRefPubMedGoogle Scholar
  34. Mulsow K, Enzlein T, Delebinski C, Jaeger S, Seifert G, Melzig MF (2016) Impact of mistletoe triterpene acids on the uptake of mistletoe lectin by cultured tumor cells. PLoS ONE 11(4):e0153825.  https://doi.org/10.1371/journal.pone.0153825 CrossRefPubMedPubMedCentralGoogle Scholar
  35. Murashige T, Skoog F (1962) A revised medium for rapid growth and bio assays with tobacco tissue cultures. Physiol Plant 15:473–497.  https://doi.org/10.1111/j.1399-3054.1962.tb08052.x CrossRefGoogle Scholar
  36. Nazaruk J, Orlikowski P (2016) Phytochemical profile and therapeutic potential of Viscum album L. Nat Prod Res 30(4):373–385.  https://doi.org/10.1080/14786419.2015.1022776 CrossRefPubMedGoogle Scholar
  37. Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79(3):629–661.  https://doi.org/10.1021/acs.jnatprod.5b01055 CrossRefPubMedGoogle Scholar
  38. Ochocka JR, Piotrowski A (2002) Biologically active compounds from European mistletoe (Viscum album L.). Can J Plant Pathol 24(1):21–28.  https://doi.org/10.1080/07060660109506966 CrossRefGoogle Scholar
  39. Oei SL, Thronicke A, Schad F (2019) Mistletoe and immunomodulation: insights and implications for anticancer therapies. Evid Based Compl Alt 2019:6.  https://doi.org/10.1155/2019/5893017 CrossRefGoogle Scholar
  40. Park YK, Do Y, Jang BC (2012) Apoptosis of K562 leukemia cells by Abnobaviscum F (R), a European mistletoe extract. Oncol Rep 28:2227–2232.  https://doi.org/10.3892/or.2012.2026 CrossRefPubMedGoogle Scholar
  41. Ramm H (2015) Mistletoe through cultural and medical history: the all-healing plant proves to be a cancer-specific remedy. Transl Res Biomed 4:1–10.  https://doi.org/10.1159/000375421 CrossRefGoogle Scholar
  42. Reynel M, Villegas Y, Kiene H, Werthmann PG, Kienle GS (2018) Intralesional and subcutaneous application of Viscum album L. (European mistletoe) extract in cervical carcinoma in situ: A CARE compliant case report. Medicine 97(48):13–420.  https://doi.org/10.1097/md.0000000000013420 CrossRefGoogle Scholar
  43. Sato M, Hosokawa M, Doi M (2011) Somaclonal variation is induced de novo via the tissue culture process: a study quantifying mutated cells in saintpaulia. PLoS ONE 6(8):e23541.  https://doi.org/10.1371/journal.pone.0023541 CrossRefPubMedPubMedCentralGoogle Scholar
  44. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA 69(1):7–34.  https://doi.org/10.3322/caac.21551 CrossRefPubMedGoogle Scholar
  45. Stec B (2006) Plant thionins—the structural perspective. Cell Mol Life Sci 63(12):1370–1385.  https://doi.org/10.1007/s00018-005-5574-5 CrossRefPubMedGoogle Scholar
  46. Steele ML, Axtner J, Happe A, Kröz M, Matthes H, Schad F (2014) Safety of intravenous application of mistletoe (Viscum album L.) preparations in oncology: an observational study. Evid Based Compl Alt 2014:236310.  https://doi.org/10.1155/2014/236310 CrossRefGoogle Scholar
  47. Steuer-Vogt MK, Bonkowsky V, Ambrosch P, Scholz M, Neiβ A, Strutz J, Hennig M, Lenarz T, Arnold W (2001) The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. Eur J Cancer 37(1):23–31.  https://doi.org/10.1016/S0959-8049(00)00360-9 CrossRefPubMedGoogle Scholar
  48. Tabiasco J, Pont F, Fournié J-J, Vercellone A (2002) Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity. Eur J Biochem 269(10):2591–2600.  https://doi.org/10.1046/j.1432-1033.2002.02932.x CrossRefPubMedGoogle Scholar
  49. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312–1316CrossRefGoogle Scholar
  50. Thronicke A, Oei SL, Merkle A, Matthes H, Schad F (2018) Clinical Safety of Combined Targeted and Viscum album L. therapy in oncological patients. Medicines (Basel) 5(3):100.  https://doi.org/10.3390/medicines5030100 CrossRefGoogle Scholar
  51. Tröger W, Zdrale Z, Tišma N, Matijašević M (2014) Additional therapy with a mistletoe product during adjuvant chemotherapy of breast cancer patients improves quality of life: an open randomized clinical pilot trial. Evid Based Compl Alt 2014:430518.  https://doi.org/10.1155/2014/430518 CrossRefGoogle Scholar
  52. Twardziok M, Meierhofer D, Börno S, Timmermann B, Jäger S, Boral S, Eggert A, Delebinski CI, Seifert G (2017) Transcriptomic and proteomic insight into the effects of a defined European mistletoe extract in Ewing sarcoma cells reveals cellular stress responses. BMC Complement Altern Med 17(1):237.  https://doi.org/10.1186/s12906-017-1715-2 CrossRefPubMedPubMedCentralGoogle Scholar
  53. Ueno M, Kakinuma Y, Yuhki K, Murakoshi N, Iemitsu M, Miyauchi T, Yamaguchi I (2006) Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. J Pharmacol Sci 101(2):151–158.  https://doi.org/10.1254/jphs.FP0050980 CrossRefPubMedGoogle Scholar
  54. Urech K, Baumgartner S (2015) Chemical constituents of Viscum album L.: implications for the pharmaceutical preparation of mistletoe. Transl Res Biomed 4:11–23.  https://doi.org/10.1159/000375422 CrossRefGoogle Scholar
  55. Urech K, Schaller G, Jäggy C (2006) Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts iscador. Arzneimittelforschung 56(06):428–434.  https://doi.org/10.1055/s-0031-1296808 CrossRefPubMedGoogle Scholar
  56. Urech K, Jäggy C, Schaller G (2009) Räumliche und zeitliche Dynamik der Viscotoxinund Mistellektingehalte in der Mistel (Viscum album L.). In: Scheer R, Alban S, Becker H, Holzgrabe U, Kemper FH, Kreis W, Matthes H, Schilcher H, Schilcher H (eds) Die Mistel in der Tumortherapie 2. Aktueller Stand der Forschung und klinische Anwendung. KVC Verlag, EssenGoogle Scholar
  57. Veerappa R, Gayatri MC (2012) Isolation of somaclonal variants for morphological and biochemical traits in Curcuma longa (turmeric). Res Plant Biol 2(3):31–37Google Scholar
  58. Vijay R, Raina SN (2000) Genetic fidelity of organized meristem-derived micropropagated plants: a critical reappraisal. Vitro Cell Dev Biol Plant 36(5):319–330.  https://doi.org/10.1007/s11627-000-0059-6 CrossRefGoogle Scholar
  59. Voelter W, Wacker R, Stoeva S, Tsitsilonis R, Betzel C (2005) Mistletoe lectins, structure and function. Front Nat Prod Chem 1:149–162.  https://doi.org/10.2174/1574089054583597 CrossRefGoogle Scholar
  60. Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. J Biol Chem 279(24):25535–25543.  https://doi.org/10.1074/jbc.M400944200 CrossRefPubMedGoogle Scholar
  61. Wright GD (2018) Unlocking the potential of natural products in drug discovery. Microb Biotechnol 12(1):55–57.  https://doi.org/10.1111/1751-7915.13351 CrossRefPubMedPubMedCentralGoogle Scholar
  62. Wu D, Yotnda P (2011) Production and detection of reactive oxygen species (ROS) in cancers. J Vis Exp 57:3357.  https://doi.org/10.3791/3357 CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of Biotechnology, Faculty of Applied Biotechnology and BiologyAgricultural University of AthensAthensGreece
  2. 2.Institute of Nuclear & Radiological Sciences & Technology, Energy & SafetyNational Center for Scientific Research “Demokritos”AthensGreece
  3. 3.Department of Solid State PhysicsNKUAAthensGreece

Personalised recommendations